ARIPIRAZOLE - search results

Australia - English - Department of Health (Therapeutic Goods Administration)

alembic aripirazole aripiprazole 20 mg tablet bottle

alembic pharmaceuticals australia pty ltd - aripiprazole, quantity: 20 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; microcrystalline cellulose; crospovidone; hyprolose; maize starch; silicon dioxide - alembic aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,acute treatment of manic or mixed episodes associated with bipolar i disorder in adults as monotherapy and in combination with lithium or valproate;,maintenance treatment of manic or mixed episodes in bipolar i disorder in adults as monotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

alembic aripirazole aripiprazole 30 mg tablet blister pack

alembic pharmaceuticals australia pty ltd - aripiprazole, quantity: 30 mg - tablet, uncoated - excipient ingredients: magnesium stearate; crospovidone; hyprolose; lactose monohydrate; silicon dioxide; microcrystalline cellulose; maize starch; iron oxide red - alembic aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,acute treatment of manic or mixed episodes associated with bipolar i disorder in adults as monotherapy and in combination with lithium or valproate;,maintenance treatment of manic or mixed episodes in bipolar i disorder in adults as monotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

alembic aripirazole aripiprazole 5 mg tablet blister pack

alembic pharmaceuticals australia pty ltd - aripiprazole, quantity: 5 mg - tablet, uncoated - excipient ingredients: maize starch; crospovidone; indigo carmine aluminium lake; hyprolose; magnesium stearate; microcrystalline cellulose; silicon dioxide; lactose monohydrate - alembic aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,acute treatment of manic or mixed episodes associated with bipolar i disorder in adults as monotherapy and in combination with lithium or valproate;,maintenance treatment of manic or mixed episodes in bipolar i disorder in adults as monotherapy.